Benefits of reducing LDL cholesterol among 18,686 patients with diabetes: Meta-analysis of 14 radomized trials of a statin versus control

Benefits of reducing LDL cholesterol among 18,686 patients with diabetes: Meta-analysis of 14 radomized trials of a statin versus control

書目詳細資料
Main Authors:	Kearney, P, Blackwell, L, Armitage, J, Keech, T, Simes, J, Collins, R, Baigent, C
格式:	Conference item
出版:	2006

相似書籍

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.
由: Kearney, P, et al.
出版: (2008)

Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy.
由: Emberson, J, et al.
出版: (2012)

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.
由: Mihaylova, B, et al.
出版: (2012)

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.
由: Baigent, C, et al.
出版: (2005)

Efficacy and safety of more intensive lowering of LDL cholesterol Reply
由: Baigent, C, et al.
出版: (2011)

Efficacy and safety of more intensive lowering of LDL cholesterol Reply
由: Baigent, C, et al.
出版: (2011)

Statins and diabetes - Authors' reply
由: Kearney, P, et al.
出版: (2008)

Statins and diabetes - Reply
由: Kearney, P, et al.
出版: (2008)

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised controlled trials of statins (vol 366, pg 1267, 2005)
由: Baigent, C, et al.
出版: (2008)

Cost-effectiveness of lowering LDL cholesterol with statins and ezetimibe in chronic kidney disease
由: Mihaylova, B, et al.
出版: (2019)

Efficacy and safety of cholesterol-lowering treatment - Reply
由: Baigent, C, et al.
出版: (2006)

Efficacy and safety of cholesterol-lowering treatment - Reply
由: Baigent, C, et al.
出版: (2006)

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.
由: Baigent, C, et al.
出版: (2010)

The role of statins in clinical medicine -LDL - cholesterol lowering and beyond
由: Swiss Medical Weekly
出版: (2006-01-01)

Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials
由: Cholesterol Treatment Trialists' Collaboration, et al.
出版: (2016)

LDL cholesterol targets--how low to go?
由: Bulbulia, R, et al.
出版: (2012)

Misrepresentation of statin safety evidence.
由: Armitage, J, et al.
出版: (2014)

Evaluation of statin use on LDL cholesterol levels in Turkey: A systematic review
由: Pınar Kızılırmak, et al.
出版: (2020-03-01)

Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins
由: Postmus, I, et al.
出版: (2014)

Lessons from the controversy over statins - Authors' reply.
由: Armitage, J, et al.
出版: (2016)

Effect of statins on LDL cholesterol and lower risk of cardiovascular complications. Which medication to choose?
由: N. M. Savina, et al.
出版: (2016-12-01)

Treatment strategies and LDL cholesterol target attainment in patients with statin intolerance: Insights from the multicentre statin intolerance registry
由: Paulina E. Stürzebecher, et al.
出版: (2025-03-01)

Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship with cardiovascular events
由: Masashi Sakuma, et al.
出版: (2022-11-01)

Statins for people at low risk of cardiovascular disease reply
由: Mihaylova, B, et al.
出版: (2012)

Statins: are any questions unanswered?
由: Kearney, P, et al.
出版: (2006)

Randomized trial of cholesterol-lowering and antioxidant vitamins in 7,000 high-risk individuals with LDL cholesterol below 120 mg/dl
由: Collins, R, et al.
出版: (2002)

Cholesterol, statins, and mortality - Reply
由: Lewington, S, et al.
出版: (2008)

Safety and efficacy of statins - Authors' reply
由: Collins, R, et al.
出版: (2017)

Statin treatment and LDL-cholesterol treatment goal attainment among individuals with familial hypercholesterolaemia in primary care
由: Joe Kai, et al.
出版: (2021-12-01)

Differential influences of LDL cholesterol on functional outcomes after intravenous thrombolysis according to prestroke statin use
由: You-Ri Kang, et al.
出版: (2022-09-01)

Long-term cardiovascular risks and statin treatment impact on socioeconomic inequalities: microsimulation model
由: Wu, R, et al.
出版: (2023)

Effects of lowering LDL cholesterol on progression of kidney disease.
由: Haynes, R, et al.
出版: (2014)

Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS).
由: Charlton-Menys, V, et al.
出版: (2009)

Cholesterol, statins, and mortality - Authors' reply
由: Lewington, S, et al.
出版: (2008)

Need for large scale randomised evidence about lowering LDL cholesterol in people with diabetes mellitus: MRC/BHF heart protection study and other major trials.
由: Armitage, J, et al.
出版: (2000)

Quo vadis, LDL cholesterol?
由: Cobos Andrés, et al.
出版: (2023-05-01)

Greater absolute reductions in LDL cholesterol should yield greater proportional reductions in risk of cardiovascular disease.
由: Clarke, R, et al.
出版: (2009)

Randomised placebo controlled trial of effect on mood of lowering cholesterol concentration. Oxford Cholesterol Study Group.
由: Wardle, J, et al.
出版: (1996)

Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
由: Storey, B, et al.
出版: (2017)

Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling study
由: Mihaylova, B, et al.
出版: (2024)